KEY TAKEAWAYS
- Q2 FY2027 revenue: $875.7M, up 9% YoY. Non-GAAP EPS: $1.16, beating the $1.08 estimate by 7.4%. Non-GAAP operating income: $277M, up 16%, with operating margin expanding 180 bps to 31.6%.
- Free cash flow: $296M, up 35% YoY, representing 34% of revenue. Share buybacks: $307M in the quarter, reducing diluted shares by 8% YoY. Raised full-year revenue guidance to $3.499B to $3.507B.
- IAM (Intelligent Agreement Management) platform now represents 15.1% of ARR, up from lower levels at launch. International revenue: 29% of total. Net revenue retention held stable. Management raised underlying growth confidence citing FX and AI tailwinds.
DocuSign spent several years being dismissed as a pandemic-era beneficiary whose growth was going to mean-revert once offices reopened. The argument was that digital signatures were a COVID habit that would fade. It didn't work that way. Revenue growth has stayed in the high single digits, the margin expansion story has gotten better each quarter, and the IAM platform — which repositions DocuSign from a digital signature utility into an AI-powered contract intelligence product — is gaining real traction. The Q2 results are the clearest version of this story yet.
What they reported
Total Q2 FY2027 revenue of $875.7 million, up 9% year-over-year on an as-reported basis. After adjusting for foreign exchange and digital add-ons, underlying growth accelerated by nearly one percentage point, a sign the core business is healthy beneath the headline. Non-GAAP operating income of $277 million, up 16%, with margin expanding 180 basis points to 31.6%. Non-GAAP gross margin: 81.7%, slightly lower than the prior year due to cloud migration investments. Non-GAAP EPS: $1.16, up 26% year-over-year. GAAP EPS: $0.40, up 33%. Free cash flow: $296 million, up over 35% year-over-year. The company bought back $307 million in stock during the quarter, reducing diluted shares outstanding by 8% year-over-year. Annual recurring revenue grew 9% year-over-year.
Beat or miss
Beat on both lines and raised full-year guidance. Revenue guidance lifted to $3.499 billion to $3.507 billion, implying roughly 9% full-year growth at the midpoint. ARR growth expected in the 8.5% to 9% range. Shares moved higher in after-hours trading on the results, reversing what had been a cautious setup heading into the print. The 7.4% EPS beat was the larger surprise relative to the revenue beat of roughly 1%.
What IAM actually is and why 15.1% of ARR matters
DocuSign's core business is e-signatures. You get a PDF, you sign it digitally, done. That product works, it's deeply embedded into corporate workflows, and it has genuine switching costs because the audit trail, compliance documentation, and integrations with document management systems are hard to replicate. But it's also a utility — priced like one, growing like one, valued like one.
IAM — Intelligent Agreement Management — is the attempt to move DocuSign up the value chain from "signature tool" to "contract intelligence platform." The pitch: companies have thousands of contracts with suppliers, customers, employees, and regulators. Most of those contracts sit in PDF files that nobody reads after signing. IAM uses AI to extract, analyze, monitor, and act on the obligations and data inside those contracts — renewal dates, pricing escalators, compliance triggers, obligation tracking. It turns the signed document from a static file into a living data source.
At 15.1% of ARR, IAM has moved from a small pilot program to a meaningful portion of DocuSign's revenue base. The significance is pricing: IAM contracts carry higher average selling prices than standalone e-signature subscriptions. Growth in IAM ARR is therefore additive to overall ARR growth and pushes the revenue mix toward higher-value agreements. Management's commentary about IAM gaining traction without specifying precise growth rates is frustrating from an analytical standpoint but suggests the trajectory is positive enough to highlight without overpromising on specifics.
The international and free cash flow story
International revenue at 29% of total was a bright spot, particularly in Asia-Pacific. Foreign exchange provided a tailwind in Q2, which management expects to continue modestly into Q3. The 35% year-over-year increase in free cash flow to $296 million is the more durable signal. A software company generating 34% of revenue as free cash flow is operating well above industry averages. That cash is flowing predominantly into buybacks — $307 million in the quarter alone — which is the mechanism reducing diluted share count by 8% year-over-year and compounding EPS growth faster than revenue growth. It's basic but effective math: if revenue grows 9% and share count falls 8%, EPS grows at a significantly faster rate than the top line.
The cloud migration investments suppressing gross margin slightly are a known and temporary headwind. Management has signaled these investments peak in fiscal 2027 and start to generate efficiency benefits thereafter. If the gross margin returns toward 82–83% as the migration completes, the operating leverage that's already visible in the model gets materially stronger.
The one thing beginners should take away
DocuSign is not a growth-at-all-costs story. It's a cash generation and capital return story built on a deeply embedded software product that 1.4 million customers already depend on. The 9% top-line growth won't excite people who want hypergrowth. The 35% free cash flow growth, the 8% share count reduction, the 180 bps of operating margin expansion, and the IAM platform building toward a higher-ASP product mix are the actual investment thesis. Whether IAM can meaningfully accelerate the overall growth rate from 9% toward 12–13% is the open question. At 15.1% of ARR and rising, the market is starting to price in a version where the answer is yes.